Michelle Mattingly
University of South Florida
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michelle Mattingly.
Neurology | 2006
Kevin R. Nelson; Michelle Mattingly; Sherman A. Lee; Frederick A. Schmitt
The neurophysiologic basis of near death experience (NDE) is unknown. Clinical observations suggest that REM state intrusion contributes to NDE. Support for the hypothesis follows five lines of evidence: REM intrusion during wakefulness is a frequent normal occurrence, REM intrusion underlies other clinical conditions, NDE elements can be explained by REM intrusion, cardiorespiratory afferents evoke REM intrusion, and persons with an NDE may have an arousal system predisposing to REM intrusion. To investigate a predisposition to REM intrusion, the life-time prevalence of REM intrusion was studied in 55 NDE subjects and compared with that in age/gender-matched control subjects. Sleep paralysis as well as sleep-related visual and auditory hallucinations were substantially more common in subjects with an NDE. These findings anticipate that under circumstances of peril, an NDE is more likely in those with previous REM intrusion. REM intrusion could promote subjective aspects of NDE and often associated syncope. Suppression of an activated locus ceruleus could be central to an arousal system predisposed to REM intrusion and NDE.
Journal of The American Pharmacists Association | 2005
Kimberly K Daugherty; J.S. Butler; Michelle Mattingly; Melody Ryan
OBJECTIVESnTo determine the percentages of patients who discontinued treatment with the multiple sclerosis medications intramuscular interferon beta-1a (IFN-beta-1a; Avonex-Biogen), interferon beta-1b (IFN-beta-1b; Betaseron-Berlex), and glatiramer acetate (Copaxone-Teva) and to determine the factors that led to discontinuation of the medications.nnnDESIGNnCross-sectional study.nnnSETTINGnUniversity-based neurology clinic.nnnPATIENTSn108 patients with multiple sclerosis who were prescribed intramuscular interferon beta-1a, subcutaneous interferon beta-1b, or subcutaneous glatiramer acetate.nnnINTERVENTIONnTelephone survey.nnnMAIN OUTCOME MEASURESnDiscontinuation percentages and the factors that contributed to discontinuation.nnnRESULTSnThere was no significant difference between the percentages of patients who discontinued and did not restart treatment with the products (interferon beta-1b, 41%; intramuscular interferon beta-1a, 34%; and glatiramer acetate, 28%). Four main reasons for medication discontinuation emerged: adverse effects (52%), physician-documented disease progression (40%), patient perception of drug ineffectiveness (20%), and cost (4%). No statistical differences were identified among the three agents for any of the reasons for discontinuation.nnnCONCLUSIONnPatient education on adverse effects and realistic patient expectations may be potential areas of study to improve discontinuation percentages with these agents.
Neurology | 2007
Kevin R. Nelson; Michelle Mattingly; Frederick A. Schmitt
In a study of more than 13,000 Europeans, 5.8% reported the out-of-body experience (OBE) form of autoscopy.1 Occurring in diverse clinical settings, OBE is also typical of near death experience (NDE). NDE are responses to life-threatening crisis characterized by a combination of dissociation from the physical body, euphoria, and transcendental or mystical elements. Persons with NDE may have an arousal system predisposed to allowing intrusion of REM sleep elements during the transition between wakefulness and sleep.2 The arousal system is comprised of brainstem structures controlling or influencing sleep-wake states, alertness, and attention. REM intrusion manifests as the atonia of sleep paralysis (or cataplexy), as well as visual or auditory hallucinations. Although not considered REM intrusion, OBE and the REM state have an established relationship that is incompletely understood. In the state boundary disorder of narcolepsy, individuals often give accounts of OBE,3,4 which diminish after the narcolepsy is treated.4 In this study, we investigated if OBE in subjects with NDE could be regarded an arousal phenomenon by occurring during sleep transition or corresponding to REM intrusion.nnStructured interviews were conducted and REM intrusion measured in 55 subjects with NDE, and compared to age- and gender-matched controls as previously described.2 All gave informed consent as approved by the institutional review board. OBE during NDE was determined by the Greyson questionnaire asking if the respondent “Clearly left the body and existed outside it.” For OBE of sleep transition, subjects …
Clinical Neuropsychologist | 2010
Eric Rinehardt; Kevin Duff; Mike R. Schoenberg; Michelle Mattingly; Kersi J. Bharucha; James Scott
Cognitive change following bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) surgery in those with Parkinsons disease (PD) has led to equivocal results. The current study applied a standardized regression-based (SRB) method based on 20 medically managed PD patients and 20 STN DBS PD surgical patients who were administered the Repeatable Battery of Neuropsychological Status (RBANS). Of the medically managed PD participants, 94% remained stable compared to 73% of the DBS group. In the DBS group cognitive change was noted on the Total scale and the Immediate Memory Index. A secondary analysis also revealed reliable change on several subtest scores. Although preliminary, the current study provides change parameters for post DBS surgery on this brief battery.
Clinical Neuropsychologist | 2012
Mike R. Schoenberg; Eric Rinehardt; Kevin Duff; Michelle Mattingly; Kersi J. Bharucha; James Scott
Parkinsons disease (PD) is progressive neurological disease characterized by resting tremor, rigidity, akinesia, postural instability and cognitive changes. The symptoms of PD are debilitating and often become unsatisfactorily treated by medication. Deep brain stimulation (DBS) is an effective treatment to significantly reduce the cardinal motor symptoms of PD. However, the neuropsychological effects of this treatment are less clear. This study examined pre- to post-DBS scores on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) using Reliable Change Indices (RCIs) derived from 20 patients with PD who were medically managed, and then compared to 20 patients with PD treated with DBS and medication. When using group statistical analyses and false discovery rate correction, no significant differences between or within groups were evident at baseline or at follow-up. However, when using the RCIs more patients in the DBS group exhibited reliable change in RBANS scores than did the Med Tx group. Although preliminary, these RCIs provide clinicians and researchers a foundational tool for assessing the effects of interventions (e.g., DBS) independent of the effects of PD and measurement error when using the RBANS.
Dementia and Geriatric Cognitive Disorders | 2014
Eric Rinehardt; Katie Eichstaedt; John A. Schinka; David A. Loewenstein; Michelle Mattingly; Jean M. Fils; Ranjan Duara; Mike R. Schoenberg
Background/Aims: Verbal fluency patterns can assist in differential diagnosis during neuropsychological assessment and identify individuals at risk for developing Alzheimers disease (AD). While evidence suggests that subjects with AD perform worse on category fluency than letter fluency tasks, the pattern in mild cognitive impairment (MCI) is less well known. Methods: Performance on the Controlled Oral Word Association Test (COWAT) and Animal fluency was compared in control, amnestic MCI, non-amnestic MCI, and AD groups. The sample included 136 participants matched for age, education, and gender. Results: Both MCI groups performed similarly with a category > letter fluency pattern rather than a category < letter fluency pattern typically observed in AD. The pattern in MCI, albeit relatively more impaired than in controls, was more similar to healthy controls who exhibited a category > letter fluency pattern. Conclusion: MCI using a category < letter fluency pattern may not represent AD; however, future research requires longitudinal studies of pattern analysis.
Epilepsy & Behavior | 2014
Jason R. Soble; Katie Eichstaedt; Hena Waseem; Michelle Mattingly; Selim R. Benbadis; Ali M. Bozorg; Fernando L. Vale; Mike R. Schoenberg
This study evaluated the accuracy of the Wechsler Memory Scale--Fourth Edition (WMS-IV) in identifying functional cognitive deficits associated with seizure laterality in localization-related temporal lobe epilepsy (TLE) relative to a previously established measure, the Rey Auditory Verbal Learning Test (RAVLT). Emerging WMS-IV studies have highlighted psychometric improvements that may enhance its ability to identify lateralized memory deficits. Data from 57 patients with video-EEG-confirmed unilateral TLE who were administered the WMS-IV and RAVLT as part of a comprehensive presurgical neuropsychological evaluation for temporal resection were retrospectively reviewed. We examined the predictive accuracy of the WMS-IV not only in terms of verbal versus visual composite scores but also using individual subtests. A series of hierarchal logistic regression models were developed, including the RAVLT, WMS-IV delayed subtests (Logical Memory, Verbal Paired Associates, Designs, Visual Reproduction), and a WMS-IV verbal-visual memory difference score. Analyses showed that the RAVLT significantly predicted laterality with overall classification rates of 69.6% to 70.2%, whereas neither the individual WMS-IV subtests nor the verbal-visual memory difference score accounted for additional significant variance. Similar to previous versions of the WMS, findings cast doubt as to whether the WMS-IV offers significant incremental validity in discriminating seizure laterality in TLE beyond what can be obtained from the RAVLT.
Archives of Clinical Neuropsychology | 2016
Jason R. Soble; Katie E. Osborn; Michelle Mattingly; Fernando L. Vale; Selim R. Benbadis; Nancy T. Rodgers-Neame; Mike R. Schoenberg
This study investigated the Word Memory Test (WMT) Free Recall (FR) subtest as a conventional memory measure. Nineteen participants with pharmacoresistant left temporal lobe epilepsy (LTLE) and 16 with right temporal lobe epilepsy (RTLE) completed the WMT, Rey Auditory Verbal Learning Test (RAVLT), and Wechsler Memory Scale-Fourth Edition Logical Memory (LM) subtest during presurgical evaluation. LTLE participants performed significantly worse on FR subtest (p < .05, [Formula: see text]) and RAVLT Trial 7 (p < .01, [Formula: see text]), but not on LM subtest. Age was a significant covariate for FR (p < .01, [Formula: see text]). Logistic regression revealed FR plus age and RAVLT age-adjusted T-scores both yielded 77.1% classification accuracy and respective diagnostic odds ratios of 11.36 and 11.84. Receiver operating characteristic curves to classify seizure laterality found that RAVLT and FR were significant (area under the curve [AUC] = 0.82 and 0.74), whereas LM was nonsignificant (AUC = 0.67). Cut scores and positive/negative predictive values were established for improved clinical classification.
Dementia and Geriatric Cognitive Disorders | 2012
Amos D. Korczyn; Oliver Kaut; Alfredo Ramirez; Heike Pieper; Ina Schmitt; Frank Jessen; Ullrich Wüllner; Rebecca L. Koscik; Asenath La Rue; Erin Jonaitis; Ozioma C. Okonkwo; Sterling C. Johnson; Barbara B. Bendlin; Bruce P. Hermann; Mark A. Sager; Veronika Vakhapova; Tzafra Cohen; Yael Richter; Yael Herzog; Yossi Kam; Susanne Tholen; Christoph Schmaderer; Ekatharina Kusmenkov; Stefan Chmielewski; Hans Förstl; Victoria Kehl; Uwe Heemann; Marcus Baumann; Timo Grimmer; Kenichi Meguro
The first page of the text should include an abstract of up to 10 lines. It should be structured as follows: Background/Aims: What is the major problem that prompted the study? Methods: How was the study carried out? Results: Most important findings? Conclusion: Most important conclusion? Footnotes: Avoid footnotes. Abbreviations: Abbreviations should not be used excessively in the text. Only standard abbreviations should be used. Nonstandard abbreviations of terms that are used frequently in the text should be explained by the term written out completely and followed immediately by the abbreviation in parentheses, for example: ‘increase in norepinephrine (NE) content ...’ . Tables and illustrations: Tables are part of the text. Place them at the end of the text file. Illustration data must be stored as separate files. Do not integrate figures into the text. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. Color illustrations Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends. Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 800.– per page. References: In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Examples (a) Papers published in periodicals: Allain H, BentueFerrer D, Tribut O, Pinel J-F: Drugs and vascular dementia. Dement Geriatr Cogn Disord 2003;16:1–6. (b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858. (c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996. (d) Edited books: Tarou LR, Bloomsmith MA, Hoff MP, Erwin JM, Maple TL: The behavior of aged great apes; in Erwin JM, Hof PR (eds): Aging in Nonhuman Primates. Interdiscipl Top Gerontol. Basel, Karger, 2002, vol 31, pp 209–231. Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists. Digital Object Identifier (DOI) S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org. Supplementary Material Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. In general, supplementary files should not exceed 10 MB in size. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Acceptable files and formats are: Word or PDF files, Excel spreadsheets (only if the
Alzheimer Disease & Associated Disorders | 2006
Kara A. Bottiggi; Marta S. Mendiondo; Michelle Mattingly; Charles D. Smith; Gregory E. Cooper; Gregory A. Jicha; Frederick A. Schmitt
Older Adults, Mild Cognitive Impairment, and Dementia Kara A. Bottiggi*, Marta Mendiondowz, Michelle Mattinglyy, Charles Smithzy, Gregory Cooperzy, Gregory Jichazy, and Frederick SchmittzyJ. *Graduate Center for Gerontology; Departments of wStatistics; yNeurology; JBehavioral Science and Psychiatry; and zSanders-Brown Center on Aging, University of Kentucky, Lexington, KY. Objective: The purpose of this study was to investigate the ability of literacy to predict global cognitive function and memory in a group of normal older adults and older adults with mild cognitive impairment (MCI) or dementia. Background: The literature shows that older adults with low education are diagnosed with dementia earlier and exhibit a slower progression than those with higher education, often proposed to reflect varying levels of cognitive reserve. Recent studies have shown that literacy may be a more accurate proxy of cognitive reserve than education due to qualitative differences in educational experiences. Design/Methods: This study consisted of older adults (N=100) referred to a memory disorders clinic for evaluation. The predictive ability of education, literacy (National Adult Reading Test Full Scale IQ: NARTFSIQ), and diagnosis on global cognitive ability (Wechsler Adult Intelligence Scale Full-Scale IQ; WAIS-FSIQ) and memory [Logical Memory I (LMI) and Visual Reproduction I (VRI) of the Wechsler Memory Scale; WMS] were examined using 3 general linear models. Results: The NART-FSIQ (P<0.001), education (P=0.007), and diagnostic group (P<0.001) were significant predictors of WAIS-FSIQ (R=0.67). The NART-FSIQ (P<0.001) and diagnostic group (P<0.001) were significant predictors of VRI (R=0.28) scores. The NART-FSIQ (P<0.001) and diagnostic group (P<0.001) were significant predictors of LMI (R=0.32) scores. Conclusions: Literacy was found to be a more robust predictor than education for measures of intellectual and memory function in normals, MCI, and dementia cases. The strongest predictive model was found for the WAIS-FSIQ followed by the LMI and VRI, which can be explained by the domains evaluated and the pattern of cognitive deficits for MCI and dementia. The results of this pilot study suggest that age and literacy, as opposed to age and education, should be used to interpret neuropsychological test results in older adults regardless of level of cognitive function. This research is supported by National Institute on Aging AG05144, and R01 AG19241.